British American Tobacco (NYSE: BTI ) has been trading at depressed valuations for years. During that time, the business kept churning out higher and higher free cash flows, yet the market has dismissed it because it has been Analyst's Disclosure:I/we have a beneficial long position in the shares of BATS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have n ...

Company Overview - Altria Group is adapting to changing industry dynamics, focusing on expanding beyond traditional cigarettes into the smokeless category due to rising health consciousness and government regulations [12] - Revenues from the oral product category are steadily increasing, driven by the growing popularity of reduced-risk products [12] Zacks Rank and Style Scores - Altria has a Zacks Rank of 3 (Hold) and a VGM Score of A, indicating a solid position in the market [13] - The company has a Momentum Style Score of B, with shares increasing by 3.9% over the past four weeks [13] - Two analysts have revised their earnings estimates upwards for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.02 to $5.37 per share [13] - Altria has an average earnings surprise of +3.3%, suggesting a positive outlook [13] Investment Considerations - With a strong Zacks Rank and high Momentum and VGM Style Scores, Altria is recommended for investors' consideration [14]

These stocks could do a lot to pump up your passive-income stream. Would your budget benefit from a significantly larger stream of passive income? There are many ways to make that happen, but I don't know of any that are easier than buying high-yield dividend stocks. Altria stock has been rising because it looks like the company's other nicotine-delivery products can offset Marlboro losses. Oral tobacco product sales rose by 6% year over year, net of excise taxes. The company could also see a tailwind from ...

Financial Data and Key Metrics Changes - Group revenue increased by 1.8%, adjusted gross profit rose by 3%, and adjusted profit from operations grew by 1.9%, with adjusted diluted EPS increasing by 1.7% [10][24][47] - The company anticipates full-year revenue at the top end of the 1% to 2% guidance, maintaining APFO guidance of 1.5% to 2.5% [10][26] Business Line Data and Key Metrics Changes - Smokeless products now account for 18.2% of Group revenue, up 70 basis points from last year, with 1.4 million new smokeless consumers added [4] - New categories revenue increased by 2.4%, driven by modern oral growth of over 40% and heated products rising by more than 3%, while vapor declined by 13% [11][12] - Combustibles revenue increased by 0.8%, with volume decline offset by strong pricing, leading to a gross profit increase of 2.4% [13][14] Market Data and Key Metrics Changes - In the U.S., revenue grew by 3.7%, with combustibles driving the growth, while modern oral revenue increased by 3.9% [16][17] - The AME region saw revenue rise by 3.5%, with combustibles up nearly 3% due to strong volumes in Brazil and Turkey [17] - APMEA experienced a total revenue decline of 4.8%, with combustibles down 7.9%, impacted by regulatory headwinds in Bangladesh and Australia [19][20] Company Strategy and Development Direction - The company is focused on a multi-category strategy to leverage consumer trends towards new categories, with significant investments in modern oral and heated products [28][30] - The introduction of the "Fit to Win" program aims to simplify operations and enhance digital decision-making, targeting £500 million in annualized savings by 2028 [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to revenue and profit growth in the U.S., highlighting the importance of regulatory affairs and enforcement for smokeless alternatives [6][41] - The company remains optimistic about the long-term growth potential of modern oral products, especially in emerging markets [30][31] Other Important Information - The company has increased its 2025 share buyback program by £200 million to £1.1 billion, reflecting strong cash generation and commitment to shareholder returns [4][25] - The company has delivered nearly £900 million in productivity savings since 2023 and aims to exceed £1.2 billion by year-end [21] Q&A Session Summary Question: Can you discuss the early performance of GloHilo in Japan and its rollout plans? - Management reported positive feedback from Japanese consumers, with a tailored product offering leading to early market share gains. The rollout will focus on high-profit pools through the end of the year [52][54] Question: What is the current momentum for VeloPlus in the U.S.? - VeloPlus is maintaining strong momentum with high retention rates and increasing market share, despite competitive pressures [57][58] Question: Can you clarify the Fit to Win program's costs and savings? - The program will have some costs in 2025, with a target of £500 million in annualized savings by 2028, which will be reinvested into growth initiatives [61][62] Question: What is the outlook for the vape business in the AME region? - The vape business is facing challenges in Canada due to regulations, but there is potential for growth as the market transitions to closed systems [66][70] Question: How is the company addressing the illegal vapor market in the U.S.? - Management noted a 40% reduction in illegal vapor shipments, with ongoing efforts to enforce regulations and improve market conditions [74][76] Question: What is the impact of the duty drawback on U.S. business? - The duty drawback is positively impacting the top line, but the company is also seeing growth from improved market share and pricing strategies [97][100] Question: Is there capacity to meet the expected growth in VeloPlus? - The company is well-equipped to handle the growth in VeloPlus, with no anticipated capacity shortages [102]

Financial Performance - HY25 total revenue reached £12567 million, a 18% increase compared to HY24 at constant rates[32] - New Category revenue grew by 24% to £1689 million[32] - Adjusted profit from operations increased by 19% to £5435 million, adjusted for Canada[32] - Adjusted diluted earnings per share (EPS) increased by 17% to 1621 pence, adjusted for Canada[32] New Categories - Smokeless products represent 182% of Group revenue, an increase of 70bps[28] - New Category contribution margin increased by 28 percentage points to 106%[28] - Velo Plus experienced strong volume share gains, up 87 percentage points from November 2024 to May 2025[89] Regional Performance - The U S saw a return to revenue and profit growth, driven by combustibles recovery and Velo Plus momentum[30, 46] - In the U S , Velo revenue grew by 384%[46] - Combustibles revenue in the U S increased by 38%[46] - APMEA was impacted by combustibles fiscal and regulatory headwinds, with a revenue decrease of 48%[52] Strategic Initiatives - The company increased its share buy-back program to £11 billion for FY25[28, 30] - The company is targeting >£12 billion in productivity savings from 2023-2025[59] - The company is aiming to generate >£50 billion in free cash flow by the end of 2030[69]

Core Insights - Altria Group Inc. reported second-quarter 2025 results with both revenue and earnings exceeding expectations and showing year-over-year growth [1][2][11] Financial Performance - Adjusted earnings per share (EPS) for the second quarter were $1.44, an increase of 8.3% year over year, surpassing the Zacks Consensus Estimate of $1.37 [2][11] - Net revenues totaled $6,102 million, a decline of 1.7% year over year, primarily due to decreased revenues in the smokeable products segment, partially offset by growth in oral tobacco products [3][11] - Revenues net of excise taxes increased by 0.2% to $5,290 million, beating the consensus estimate of $5,190 million [3] Segment Performance - **Smokeable Products**: Net revenues fell 2.5% year over year to $5,357 million, driven by reduced shipment volumes, although higher pricing provided some offset [4][5] - Domestic cigarette shipment volumes decreased by 10.2%, attributed to industry decline and retail share losses, while cigar shipment volumes increased by 3.7% [5] - Adjusted operating companies' income (OCI) in this segment rose 4.2% to $2,947 million, with adjusted OCI margins growing by 2.9 percentage points to 64.5% [6] - **Oral Tobacco Products**: Net revenues increased by 5.9% to $753 million, mainly due to higher pricing, despite a decline in domestic shipment volumes by 1% [7][8] - Adjusted OCI in this segment grew by 10.9%, with adjusted OCI margins increasing by 3.1 percentage points to 68.7% [8] Shareholder Returns and Guidance - The company repurchased 4.7 million shares for $274 million in the second quarter, with $400 million remaining under its $1 billion share repurchase program [10] - Altria paid dividends totaling $1.7 billion in the second quarter [10] - The company narrowed its full-year 2025 adjusted EPS guidance to a range of $5.35 to $5.45, indicating a year-over-year growth of 3% to 5% [11][12]

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive has bureaus and studios in key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2][3] Group 2 - The company is a forward-looking technology adopter, utilizing various technologies to enhance workflows [4] - Proactive employs automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]

For the quarter ended June 2025, Altria (MO) reported revenue of $5.29 billion, up 0.3% over the same period last year. EPS came in at $1.44, compared to $1.31 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $5.19 billion, representing a surprise of +1.93%. The company delivered an EPS surprise of +5.11%, with the consensus EPS estimate being $1.37.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectation ...

Financial Data and Key Metrics Changes - Adjusted diluted earnings per share increased by 8.3% to $1.44 in the second quarter and by 7.2% for the first half [19] - Adjusted operating companies income in the Smokable Products segment grew by 4.2% to $2.9 billion in the second quarter and by 3.5% to $5.5 billion in the first half [19] - Adjusted OCI margins expanded to 64.5% for both the second quarter and the first half [20] Business Line Data and Key Metrics Changes - In the Smokable Products segment, domestic cigarette volumes declined by 10.2% in the second quarter and 11.9% for the first half [20] - Oral nicotine pouches, particularly ON!, reported a shipment volume increase of 26.5% to 52.1 million cans in the second quarter [11] - Adjusted OCI for the Oral Tobacco Products segment grew by 10.9% in the second quarter and 5.5% in the first half [23] Market Data and Key Metrics Changes - The e-vapor category included over 20.5 million vapers, up by over 1.9 million year over year [14] - Disposable vapers increased by an estimated 2.7 million to approximately 14.4 million, representing over 60% of the e-vapor category [14] - Domestic cigarette volumes at the industry level declined by an estimated 8.5% in the second quarter [20] Company Strategy and Development Direction - The company aims to shape a fully regulated industry and provide expanded product choices for adult nicotine consumers [8] - Continued focus on driving trial, building long-term equity, and increasing profitability in the ON! brand [12] - The company is actively exploring potential next steps regarding the nJoy e-vapor product line, including an appeal against patent disputes [13] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the strong performance of operating companies despite challenging market conditions [18] - The macroeconomic environment remains dynamic, with inflation and consumer confidence being key factors to monitor [32] - The company raised the lower end of its 2025 guidance range, expecting adjusted diluted EPS in the range of $5.35 to $5.45 [25] Other Important Information - The company returned over $4 billion to shareholders through dividends and share repurchases in the first half of the year [8] - The total debt to EBITDA ratio as of June 30 was 2.0 times, in line with the target [26] - The company is advocating for more coordinated actions against illicit e-vapor products to clean up the marketplace [16] Q&A Session Summary Question: Insights on the raised guidance range and consumer environment - Management highlighted the dynamic market and the need to monitor adult tobacco consumer behaviors due to inflationary pressures [31] Question: Update on nJoy e-vapor product development - Management confirmed that product development for the nJoy ACE device is progressing, with plans to file for FDA approval [35] Question: Long-term EPS growth outlook - Management remains confident in achieving mid-single-digit EPS growth through FY 2028, despite economic strains on consumers [44] Question: Strategy for the Basic brand - The company is using targeted analytics to maintain consumer loyalty and expand the Basic brand's presence in discount segments [49] Question: Impact of illicit vape crackdowns - Management noted that while enforcement actions are increasing, it is too early to determine their overall impact on the market [58] Question: Tariff impacts on business - Tariffs have had some impact on costs, particularly in supply chain materials, but are not viewed as material to overall business performance [98]

Financial Data and Key Metrics Changes - Adjusted diluted earnings per share increased by 8.3% to $1.44 in Q2 2025 and by 7.2% for the first half, driven by robust adjusted operating companies income growth and share repurchases [19][25] - Adjusted operating companies income for the Smokable Products segment grew by 4.2% to $2.9 billion in Q2 and by 3.5% to $5.5 billion in the first half [19][20] - Adjusted OCI margins expanded to 64.5% for both Q2 and the first half [20] Business Line Data and Key Metrics Changes - Oral nicotine pouches, particularly ON!, were the primary growth driver, with reported shipment volume increasing by 26.5% to 52.1 million cans year-over-year [9][23] - Domestic cigarette volumes in the Smokable Products segment declined by 10.2% in Q2 and 11.9% for the first half, with adjusted estimates showing declines of approximately 10.5% [20][21] - The Oral Tobacco Products segment saw adjusted OCI grow by 10.9% in Q2, primarily driven by ON!'s strong performance [23] Market Data and Key Metrics Changes - The e-vapor category included over 20.5 million vapers, up by 1.9 million year-over-year, with disposable vapers increasing to approximately 14.4 million [14][15] - The flavored disposable market continues to drive e-vapor category growth, representing over 60% of the category [15][16] Company Strategy and Development Direction - The company is focused on shaping a fully regulated industry and expanding product choices for adult nicotine consumers, while also advocating for enforcement against unregulated products [7][14] - The strategy includes targeted launches and promotions for the Basic brand to retain consumers in the portfolio while addressing macroeconomic pressures [21][49] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the strong performance of operating companies despite challenging market conditions and inflationary pressures [18][32] - The company raised the lower end of its 2025 guidance range, expecting adjusted diluted EPS to be in the range of $5.35 to $5.45, reflecting a growth rate of 3% to 5% from 2024 [25][26] Other Important Information - The company returned significant value to shareholders, paying approximately $3.5 billion in dividends and repurchasing 10.4 million shares for $600 million in the first half of the year [26][27] - The total debt to EBITDA ratio as of June 30 was 2.0 times, in line with the target [27] Q&A Session Summary Question: Discussion on the raised guidance range and expectations for the second half - Management acknowledged the strong first half results and the dynamic market conditions, emphasizing the need to monitor consumer behavior amid inflation [30][32] Question: Update on nJoy e-vapor product development - Management confirmed that product development for the new nJoy device is progressing, with plans to file for FDA approval once ready [34][36] Question: Long-term EPS growth outlook - Management remains confident in achieving mid-single-digit EPS growth through FY 2028, despite current economic strains on consumers [43][44] Question: Strategy for the Basic brand and discount share - The company is strategically repositioning Basic as a discount brand while using data analytics to target consumers effectively [49][50] Question: Impact of enforcement on illicit vapes and cigarette volumes - Management noted that while enforcement actions are increasing, it is too early to determine their full impact on the market [55][58] Question: Clarification on tariff impacts - Management indicated that while tariffs have affected costs, they do not view them as material to overall business performance [96][97]